A detailed history of Main Management ETF Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 197,104 shares of GERN stock, worth $721,400. This represents 0.04% of its overall portfolio holdings.

Number of Shares
197,104
Holding current value
$721,400
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$4.17 - $4.99 $821,923 - $983,548
197,104 New
197,104 $895,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Main Management ETF Advisors, LLC Portfolio

Follow Main Management ETF Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Management ETF Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Management ETF Advisors, LLC with notifications on news.